Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.2104
+0.0144 (7.35%)
At close: Dec 31, 2025, 4:00 PM EST
0.2104
0.00 (0.00%)
After-hours: Dec 31, 2025, 8:00 PM EST
Theriva Biologics Market Cap
Theriva Biologics has a market cap or net worth of $7.1 million as of December 31, 2025. Its market cap has increased by 115.12% in one year.
Market Cap
7.10M
Enterprise Value
2.33M
1-Year Change
115.12%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since April 2, 2007, Theriva Biologics's market cap has decreased from $81.60M to $7.10M, a decrease of -91.30%. That is a compound annual growth rate of -12.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 6.60M | 34.69% |
| Dec 31, 2024 | 4.90M | -32.88% |
| Dec 29, 2023 | 7.30M | 1.39% |
| Dec 30, 2022 | 7.20M | -79.94% |
| Dec 31, 2021 | 35.90M | 366.23% |
| Dec 31, 2020 | 7.70M | -9.41% |
| Dec 31, 2019 | 8.50M | 11.84% |
| Dec 31, 2018 | 7.60M | -88.36% |
| Dec 29, 2017 | 65.30M | -7.11% |
| Dec 30, 2016 | 70.30M | -66.19% |
| Dec 31, 2015 | 207.90M | 96.32% |
| Dec 31, 2014 | 105.90M | 55.05% |
| Dec 31, 2013 | 68.30M | -11.18% |
| Dec 31, 2012 | 76.90M | 116.62% |
| Dec 30, 2011 | 35.50M | 22.84% |
| Dec 31, 2010 | 28.90M | 140.83% |
| Dec 31, 2009 | 12.00M | 224.32% |
| Dec 31, 2008 | 3.70M | -96.22% |
| Dec 31, 2007 | 97.80M | 19.85% |
| Apr 2, 2007 | 81.60M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |